CMS Entry id: 2709 | Channel: Blog landing page | Template: blog/index

Facebook YouTube Twitter Linkedin
Facebook YouTube Twitter Linkedin


25 November 2022

Emerging technology and other trends from SfN 2022

John Bernstein, Clinical Scientist at Cambridge Cognition, explores the trends and exciting developments that were discussed at the 2022 Society for Neuroscience (SfN) conference.

23 November 2022

Four key takeaways from our academic customer survey

In June 2022 we conducted a survey to find out more about what our academic customers think of Cambridge Cognition’s products and services. These surveys are a great opportunity for our customers to give us their honest and candid feedback. We had a great response and gained some very interesting insights and feedback. Here we discuss four of the main points that we learned from the survey. 

3 November 2022

Remote Web-based Assessment of Cognition, Mood and Fatigue in People with Multiple Sclerosis

This poster was presented at ECTRIMS in October 2022.

18 October 2022

2022 CANTAB Research Grant: Assessing Chemotherapy-Related Cognitive Impairment (CRCI)

We caught up with 2022 CANTAB Research Grant winner Peter Mukli, who tells us about how the grant will enable him and his team to investigate the impact of chemotherapy on cognition in breast cancer survivors. 

6 October 2022

2022 CANTAB Research Grant: Examining the relationship between BDNF and Parkinson’s Disease

Amy Tiberio was one of the winners of the 2022 CANTABTM Research Grant. Here she explains more about her project and what winning this grant means for her.

6 October 2022

Understanding the effect of ashwagandha root extract on stress, sleep and cognition

We caught up with Shefali Thanawala from Nutriventia Ltd who told us how CANTABTM helped them to investigate the effects of Ashwagandha root extract on memory and focus in healthy, stressed adults. 

30 September 2022

Mental health related differences in healthcare worker's temporal patterns of cognition, stress, mood and sleep during the COVID-19 pandemic

This poster was first presented at the British Association of Psychopharmacology (BAP) Summer Meeting in July 2022.